Platform licensing: the biotech model of many partners and shared risk, and how to borrow it

Why it works

1. A reusable engine that produces many candidates, worth more than any one of them.
2. Partners who are better placed to finish the work, and who pay for access up front.
3. Fees tied to milestones and royalties, so the platform shares in each success without paying for each failure.
4. Every partner program teaches the platform something, so it improves as it is used.

When it holds

• Finishing a product costs far more than starting one, and others are better at finishing.
• The engine can be shared without giving it away.

Where it breaks

• The platform cannot be separated from the people who run it, so partners cannot use it alone.
• Partners learn enough to build their own engine, and stop paying.
• One partner becomes most of the revenue, and the model turns into a single contract.

Where else it works

Arm

Licenses its chip designs to the companies that build chips, and earns a royalty on each chip shipped.

Dolby

Licenses its audio technology to device makers rather than building the devices.

Qualcomm

Earns a large part of its income licensing wireless patents to phone makers.

Where you could try it

• An AI model or data company
• A developer tool with a strong core engine
• A research lab with a repeatable method